Home Cart Sign in  
Chemical Structure| 142340-99-6 Chemical Structure| 142340-99-6

Structure of Adefovir Dipivoxil
CAS No.: 142340-99-6

Chemical Structure| 142340-99-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Adefovir dipivoxil can block reverse transcriptase which is crucial for the hepatitis B virus (HBV) to reproduce.

Synonyms: GS 0840

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Adefovir Dipivoxil

CAS No. :142340-99-6
Formula : C20H32N5O8P
M.W : 501.47
SMILES Code : NC1=C2N=CN(CCOCP(OCOC(C(C)(C)C)=O)(OCOC(C(C)(C)C)=O)=O)C2=NC=N1
Synonyms :
GS 0840
MDL No. :MFCD00869897
InChI Key :WOZSCQDILHKSGG-UHFFFAOYSA-N
Pubchem ID :60871

Safety of Adefovir Dipivoxil

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Adefovir dipivoxil, an oral prodrug of the nucleoside reverse transcriptase inhibitor Adefovir, is effective against both wild type and HBV strains resistant to Lamivudine[1].[2].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00042393 Chronic Hepatitis B APPROVED_FOR_MARKETING - -
NCT00307242 Chronic Hepatitis B PHASE4 COMPLETED 2009-02-05 -
NCT00023153 HIV Infections|Chronic Hepatit... More >>is B Less << PHASE3 COMPLETED 2025-10-04 National Institute of Allergy ... More >>and Infectious Diseases (NIAID), Bethesda, Maryland, 20892, United States Less <<
NCT00644761 Hepatitis B PHASE2 COMPLETED 2025-05-05 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294, United States|Cedars Sinai Medical Center, Los Angeles, California, 90048, United States|California Pacific Medical Center, San Francisco, California, 94115, United States|University of California, San Francisco, San Francisco, California, 94143, United States|University of Miami, Miami, Florida, 33136, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02115, United States|NYU Medical Center, New York, New York, 10016, United States|Columbia Presbyterian Medical Center, New York, New York, 10032, United States|Mayo Clinic, Rochester, New York, 55905, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States|Baylor Research Institute, Dallas, Texas, 75204, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.99mL

0.40mL

0.20mL

9.97mL

1.99mL

1.00mL

19.94mL

3.99mL

1.99mL

References

 

Historical Records

Categories